Olaris secures undisclosed investment from Bruker Corporation to enhance its metabolomics platform for improved disease diagnostics. The funding will support commercialization efforts.
Round Type
Venture
FraminghamBiotechnologyHealth CareInvestors
Description
Olaris, a Framingham, MA-based metabolomics and precision medicine company, received an investment from Bruker Corporation. The amount of the deal was not disclosed. The company intends to use the funds to support the continued development and commercialization of its proprietary metabolomics platform. This platform leverages machine learning and metabolite biomarker discovery for improved disease diagnostics.
Quick answer
Olaris raised an undisclosed amount in a funding round, dated May 19, 2025. Investors: Bruker Corporation. Olaris is based in Framingham, Massachusetts, United States.
- How much did Olaris raise?
- Olaris raised an undisclosed amount in a funding round on May 19, 2025.
- Who invested in Olaris?
- Bruker Corporation is named as investors in this round.
- What does Olaris do?
- Olaris is a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARIS™ diagnostics products, which aim to optimize treatments and outcomes for individual..
- Where is Olaris based and how big is it?
- Olaris is based in Framingham, Massachusetts, United States. Fundz records about 14 employees.
- Who are the decision-makers at Olaris?
- Fundz holds 2 contacts at Olaris. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Olaris that raised within 45 days of this round, from Fundz verified event records.
- Amotio raised $1.1M (Pre-Seed) on July 3, 2025.
- Ebenbuild raised $2.7M (Grant) on July 2, 2025.
- Loopworm raised $3.3M (Pre-Series A) on July 2, 2025.
- Circulate Health raised $12M (Seed) on July 2, 2025.
- Quiver Bioscience raised $2.1M (Grant) on July 1, 2025.
- FELIQS raised $9M (Series A) on July 1, 2025.
Who to call at Olaris, and when
A new round usually means Olaris is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Olaris raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Olaris, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Olaris. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Olaris raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Olaris raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.